Adage Capital Partners’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-50,000	Closed	-$11M	–	941
2023 Q2	$11M	Sell	50,000 -70,000	-58%	-$15.5M	0.02%	555
2023 Q1	$26.9M	Sell	120,000 -87,000	-42%	-$19.5M	0.06%	343
2022 Q4	$57.6M	Sell	207,000 -148,000	-42%	-$41.2M	0.14%	180
2022 Q3	$74.3M	Buy	355,000 +140,000	+65%	+$29.3M	0.18%	126
2022 Q2	$50.7M	Sell	215,000 -85,000	-28%	-$20M	0.12%	183
2022 Q1	$53.8M	Sell	300,000 -100,000	-25%	-$17.9M	0.1%	196
2021 Q4	$86.4M	Hold	400,000	–	–	0.16%	143
2021 Q3	$73.8M	Sell	400,000 -100,000	-20%	-$18.5M	0.15%	149
2021 Q2	$89.7M	Buy	500,000 +75,000	+18%	+$13.5M	0.18%	120
2021 Q1	$71.1M	Sell	425,000 -400,000	-48%	-$66.9M	0.15%	162
2020 Q4	$125M	Sell	825,000 -350,000	-30%	-$53.1M	0.27%	80
2020 Q3	$119M	Buy	1,175,000 +75,000	+7%	+$7.58M	0.3%	71
2020 Q2	$133M	Sell	1,100,000 -186,622	-15%	-$22.6M	0.34%	57
2020 Q1	$122M	Buy	1,286,622 +536,622	+72%	+$50.9M	0.36%	62
2019 Q4	$66.1M	Buy	750,000 +500,000	+200%	+$44M	0.16%	165
2019 Q3	$19.9M	Buy	250,000 +100,000	+67%	+$7.98M	0.05%	366
2019 Q2	$11.7M	Buy	+150,000	New	+$11.7M	0.03%	501